EA201001326A1 - Стерильные офтальмологические композиции и способ их получения - Google Patents

Стерильные офтальмологические композиции и способ их получения

Info

Publication number
EA201001326A1
EA201001326A1 EA201001326A EA201001326A EA201001326A1 EA 201001326 A1 EA201001326 A1 EA 201001326A1 EA 201001326 A EA201001326 A EA 201001326A EA 201001326 A EA201001326 A EA 201001326A EA 201001326 A1 EA201001326 A1 EA 201001326A1
Authority
EA
Eurasian Patent Office
Prior art keywords
production
ophthalmological compositions
sterile
sterile ophthalmological
compositions
Prior art date
Application number
EA201001326A
Other languages
English (en)
Inventor
Ашок Васантрай Вайас
Равиндра Тукарам Джадхав
Субхаш Тримбак Фад
Original Assignee
Марвел Лайфсайнсез Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Марвел Лайфсайнсез Лтд. filed Critical Марвел Лайфсайнсез Лтд.
Publication of EA201001326A1 publication Critical patent/EA201001326A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Раскрыта офтальмологическая композиция, включающая 3-гидрокси-2,4,6-триметилпиридин, его фармацевтически приемлемые соли, сложные эфиры, производные и полиморфные модификации для лечения внутриглазного кровотечения и дегенерации желтого пятна.
EA201001326A 2008-02-19 2009-02-19 Стерильные офтальмологические композиции и способ их получения EA201001326A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN355MU2008 2008-02-19
PCT/IN2009/000113 WO2009116076A2 (en) 2008-02-19 2009-02-19 Sterile opthalmic preparations and a process for preparation thereof

Publications (1)

Publication Number Publication Date
EA201001326A1 true EA201001326A1 (ru) 2011-04-29

Family

ID=41091336

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201001326A EA201001326A1 (ru) 2008-02-19 2009-02-19 Стерильные офтальмологические композиции и способ их получения

Country Status (4)

Country Link
EP (1) EP2265252A2 (ru)
CN (1) CN102006872A (ru)
EA (1) EA201001326A1 (ru)
WO (1) WO2009116076A2 (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2252265A4 (en) * 2008-02-19 2011-04-20 Marvel Lifesciences Ltd INJECTABLE PREPARATIONS AND MANUFACTURING METHOD THEREFOR
US20140018402A1 (en) * 2011-03-30 2014-01-16 Catholic University Industry Academic Cooperation Foundation Pharmaceutical composition for preventing or treating macular degeneration
CN102526282A (zh) * 2012-03-11 2012-07-04 周洁 一种降低糖尿病眼病的眼压的外用保健品
EP3530262A1 (en) 2018-02-27 2019-08-28 The Procter & Gamble Company Personal care compositions and uses
CN109030474A (zh) * 2018-06-13 2018-12-18 迦娜生物科技（武汉）有限公司 一种脂质自由基尿液检测试剂及其应用
WO2020036242A1 (ko) * 2018-08-17 2020-02-20 주식회사 나이벡 치은치주염 또는 임플란트 주위염 치료 및 예방용 조성물 및 상기 조성물이 코팅되어 있는 치간칫솔
RU2703306C1 (ru) * 2018-09-27 2019-10-16 федеральное государственное автономное учреждение "Национальный медицинский исследовательский центр "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации Способ повышения зрительных функций при эндовитреальной хирургии регматогенной отслойки сетчатки

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2276138C2 (ru) * 2004-05-12 2006-05-10 Марвел Лайф Сайнсез Лтд. Вещество, обладающее антиоксидантной, геропротекторной и противоишемической активностью, и способ его получения

Also Published As

Publication number Publication date
WO2009116076A2 (en) 2009-09-24
CN102006872A (zh) 2011-04-06
EP2265252A2 (en) 2010-12-29
WO2009116076A3 (en) 2010-01-07

Similar Documents

Publication Publication Date Title
EA201001326A1 (ru) Стерильные офтальмологические композиции и способ их получения
EP4365179A3 (en) Novel rapamycin derivatives
MY167602A (en) Amine derivatives compounds for treating ophthalmic diseases and disorders
EA201100654A1 (ru) Соединения для лечения офтальмологических заболеваний и расстройств
EA200700109A1 (ru) Способы лечения офтальмологических состояний (варианты)
WO2009091374A3 (en) Fused heterocyclic derivatives and methods of use as c-met inhibitors
WO2011091205A3 (en) Intracameral sustained release therapeutic agent implants
MX2009000531A (es) Derivados heterociclicos fusionados y metodos de uso.
MX2021010888A (es) Derivados heteroaromaticos y aromaticos heterobiciclicos para el tratamiento de trastornos relacionados con ferroptosis.
EA201071413A1 (ru) Способ и композиция для лечения повышения внутриглазного давления и глаукомы
EA201001328A1 (ru) Оральные дозированные композиции и способ их получения
PH12015501942A1 (en) Susbtituted 3-phenylpropylamine derivatives for the treatment of opthalmic diseases and disorders
EA201100462A1 (ru) Серосвязанные соединения для лечения офтальмологических заболеваний и расстройств
NZ597529A (en) Oxazine derivatives and their use as bace inhibitors for the treatment of neurological disorders
TR201802944T4 (tr) İlaç olarak azai̇ndazol veya di̇azai̇ndazol türünün türevleri̇
RU2012107109A (ru) Бициклическое соединение и его применение для медицинских целей
EP2597953A4 (en) METHOD FOR THE TREATMENT OF EYE DISEASES USING KINASE-INHIBITOR COMPOUNDS IN PRODRUG FORMS
EA201200318A1 (ru) Гетероциклические оксимы
WO2018209363A3 (en) PROPIONIC ACID DERIVATIVES AND ASSOCIATED METHODS OF USE
WO2011053768A3 (en) System and method for stabilizing corneal tissue after treatment
MX2014002107A (es) Sensibilizantes de (bacterio) clorofila para el tratamiento de enfermedades y transtornos oculares campo tecnico.
NZ754944A (en) Imidazo [1,5-a] pyrazine derivatives as pi3kdelta inhibitors
EP4100406A4 (en) COMPOSITIONS FOR THE TREATMENT OF OCULAR DISEASES
MX2012001529A (es) Derivados de 3-heteroaril-metil-imidazo-[1,2-b]-piridazin-6-ilo como moduladores de cinasa de tirosina c-met.
NZ598490A (en) Treatment of macular degeneration